CES 2019: IBM’s Ginni Rometty Pointed Out “100% of Jobs Will Be Different” Due to AI

9 Jan, 2019 03:40
source: 香港奇点财经Singularity Financial

Artificial intelligence will destroy jobs, and it will create jobs, IBM CEO Ginni Rometty said on the CES keynote stage in Las Vegas on Tuesday,  January 8, 2019. But no matter how that balance shakes out, “100 percent of jobs will be different,” she said.

The CEO talked further about the changes on the horizon because of AI, which she said will come with the advent of “broad AI.” While “narrow” is good at learning one task in one domain and general AI is human-like in its processing capabilities, broad AI falls somewhere in between — it excels at many tasks across domains. That means it should take less training data.

Dario Gil, IBM’s head of AI and quantum research, said general AI is “decades away,” but broad AI will serve as a stepping stone there.

As AI improves, Rometty said, organizations will be able to take greater advantage of “deep data” — granular data that often goes uncollected. IBM unveils system for more accurate weather forecasting, a new global weather forecasting system designed to provide more accurate and timely forecasts around the world. The IBM-owned Weather Company is using crowdsourced sensor data to improve local weather forecasting globally. IBM’s Weather Channel app has come under fire for its handling of data from cell phone users, but Rometty said the new forecasting capabilities will only tap data from individual cell phones with consent from the user.

Quantum computing is also on the horizon, Rometty said, with the introduction of IBM’s quantum computing system. It’s “not just a lab experiment, not just a chip, it is a full system,” she said.

IBM used the expo to unveil its Q System One, which it said is the world’s first integrated quantum computing system for both scientific and commercial use. Quantum computing could one day be used to find new ways to model financial data, for example, or to optimize fleet operations for deliveries, the company said. IBM Q System One is significant because it can operate outside of research labs, where this kind of technology has traditionally been confined.

In addition to unveiling the IBM Q System One, the company said it plans to open its first IBM Q Quantum Computation Center for commercial clients in Poughkeepsie, New York, this year. The center will have advanced cloud-based quantum computing systems, which members of the IBM Q Network — made up of Fortune 500 companies, startups, academic institutions and national research labs — will be able to access.

Rometty announced that ExxonMobil is the first energy company to join the IBM Q Network, a collaborative research effort to advance quantum computing. There are now more than 42 institutions in the network.

IBM received a record 9,100 patents in 2018, the company said. It had the most artificial intelligence, cloud computing, security and quantum computing-related patent grants in the industry, it noted. Last year, IBM inventors were granted 1,600 AI patterns.

The Consumer Technology Association (CTA) and IBM shared the launch of the CTA Apprenticeship Coalition, which aims to create thousands of apprenticeships in 20 US states. The goal is to help close the skills gap companies often face when hiring new employees. IBM says it’ll add at least 450 apprenticeships each year for the next five years. The CTA Apprenticeship Coalition offers more than 15 different apprenticeship roles in fields like software engineering, data science and analytics, and cybersecurity. The apprenticeships are also designed to help people with or without college degrees to work in various areas of tech.

IBM is partnering with the Michael J. Fox Foundation for Parkinson’s Research, which is sharing its vast amounts of anonymous data on Parkinson’s patients. The partnership aims to expand IBM’s work to understand and track the disease. Last year, IBM published research on how AI and machine learning can better detect changes in a person’s speech, which could indicate the progression of Parkinson’s.